Exhibit 10.6


 





EXECUTION VERSION








 


AMENDED & RESTATED EMPLOYMENT AGREEMENT


 


AMENDED & RESTATED EMPLOYMENT AGREEMENT,
dated as of April 14,2015, by and between Sequential Brands Group, Inc., a Delaware corporation (the “Company”),
and Yehuda Shmidman (the “Executive”).


 


WITNESSETH


 


WHEREAS, the Executive
is currently employed as the Chief Executive Officer of the Company pursuant to an employment agreement between the Company and
the Executive dated as of November 19, 2012 (the “Prior Agreement”); and


 


WHEREAS, the Company
and the Executive desire to amend and restate the Prior Agreement effective as of the date hereof..


 


NOW, THEREFORE, in consideration of the
mutual covenants and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the Company and Executive hereby agree as follows:


 


1.      Engagement
of Executive; Duties; Board. During the Term (as hereinafter defined in Section 3 below), the Executive shall have the title
of Chief Executive Officer of the Company reporting solely to the Company’s Board of Directors (the “Board”).
Executive will have such responsibilities, duties and authority customarily associated with the position of Chief Executive Officer.
All areas of the Company will report to Executive including, but not limited to, licensing, brand management, finance, and legal.
In connection with his employment by the Company, the Executive shall be based in the greater New York metropolitan area.


 


2.      Time.
The Executive shall devote substantially all of his working hours to his duties hereunder and towards the overall success of the
business of the Company, including but not limited to, strategic direction, execution and implementation of business plans, developing
and achieving budget targets, and overall business growth of the Company, provided that nothing contained herein shall be deemed
to restrict the Executive from engaging in charitable, religious, civic or community activities, or from serving on the boards
of directors of non-profit organizations and, with the consent of the Board (such consent not to be unreasonably withheld, delayed
or conditioned), other for-profit companies which do not compete with the Company, provided that such activities do not materially
interfere with Executive’s duties and responsibilities under this Agreement.


 


3.      Term.
The term of this Agreement shall commence on April 14, 2015 (the “Effective Date”) and shall continue until
December 31, 2018 (the “Term”) unless otherwise terminated as provided herein. In the event that the Executive
remains an employee of the Company following expiration of the Term and this Agreement is not extended, he shall be an employee
“at will” and shall not be (i) at any during or following such “at will” employment, entitled to any of
the benefits under this Agreement, or (ii) at any time following such “at will employment”, subject to any of the restrictions
contained in this Agreement (including, but not limited to, the noncompetition and non-solicitation provisions contained in Section
7), other than the undertakings contained in Section 6 and the provisions of Section 10, each of which shall
survive any termination or non-renewal of this Agreement.


 






    	 



    	 



    

  


4.      Compensation.


 


(a)          Base
Salary. During the Term, Executive’s base salary will be at a rate of not less than $600,000 per annum paid in accordance
with the Company’s payroll practices and policies then in effect, with such increases (but not decreases) as determined by
the Board or the Compensation Committee of the Board (the “Compensation Committee”) from time to time (such
salary, as increased from time to time, the “Base Salary”).


 


(b)          Bonus.
During the Term, the Executive shall be entitled to receive an annual bonus for each fiscal year (the “Annual Bonus”)
based upon the adjusted EBITDA target to be agreed to by the Company and Executive and set forth in the Board-approved budget for
the applicable year (which target shall be adjusted for the effect of the disposition of any assets prior to the end of the applicable
year). The parties shall use commercially reasonable efforts to define such target prior to the start of each applicable fiscal
year. The target Annual Bonus amount shall be one hundred fifty percent (150%) of the Base Salary and shall be paid if the adjusted
EBITDA target for the year is attained. If performance for any year is 80% or more but less than 90% of the adjusted EBITDA target
for that year, 50% on the target Annual Bonus will be paid and if performance for any year is 90% or more but less than 100% of
the adjusted EBITDA target for that year, 75% on the target Annual Bonus will be paid. In the event of a sale or other disposition
of assets, the adjusted EBITDA target for the year in which such sale or other disposition occurs shall be reduced by the amount
of EBITDA included in the budget for that year that was attributable to those assets. Annual Bonuses, if applicable, shall be due
and payable by the Company to the Executive annually, commencing with the fiscal year ended December 31, 2015, payable in the year
following the year for which such Annual Bonus was earned on the earlier of the date the Company files its 10-K or April 1st of
such year. In the event that following fiscal year 2015, the Company adopts an annual incentive plan designed to grant performance-basedcompensation
in accordance with Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), the EBITDA
targets and bonus amounts will be subject to (x) approval by the Compensation Committee in accordance with Section 162(m) of the
Code and (y) any other requirements for performance-based compensation under 162(m) of the Code.


 


(c)    Equity Compensation.


 


(i)  Prior Awards. The Executive
has received (A) an equity grant (the “Restricted Stock Award”) in the form of 396,196 restricted shares of
the Company’s common stock (the “Restricted Stock”), of which 297,147 shares of the Restricted Stock have
vested and the remaining 99,049 shares of Restricted Stock Award will vest on November 19, 2015 and (B) a grant of performance-based
restricted stock units (the “PSUs”) in respect of 300,000 shares of the Company’s common stock as of January
1, 2014 of which 60,000 shares have vested and the remaining 240,000 shares will vest based on the attainment of the performance
goals set forth in the PSU award agreement; provided, however, that upon a “Change in Control,” (i) all
unvested shares of Restricted Stock will immediately vest and (ii) all performance goals applicable to the PSUs shall be deemed
to have been satisfied and the PSUs that would have vested on the last day of each remaining performance period had all of the
performance goals been satisfied shall vest on each such day provided the Executive remains employed as of such day. For purposes
of this Agreement, a Change in Control shall mean any of the following:


 






    	2



    	 



    

  


(1)         Any
individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a “Person”)
becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 50% or more of either (A)
the then-outstanding shares of common stock of the Company (the “Outstanding Company Common Stock”) or (B) the
combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors
(the “Outstanding Company Voting Securities”); provided, however, that, for purposes of this Section
4(c)(1), the following acquisitions shall not constitute a Change in Control: (i) any acquisition by an Excluded Person (as defined
below) (ii) any acquisition directly from the Company, (iii) any acquisition by the Company, (iv) any acquisition by any employee
benefit plan (or related trust) sponsored or maintained by the Company or any affiliate or (v) any acquisition by any corporation
pursuant to a transaction that complies with Sections 4(c)(2)(A) or 4(c)(2)(B) below;


 


(2)         
Consummation of (i) a reorganization, merger, statutory share exchange or consolidation or similar transaction involving the Company
or any affiliate, (ii) a sale or other disposition of all or substantially all of the assets of the Company, or (iii) the acquisition
of assets or stock of another entity by the Company or any affiliate (each, a “Business Combination”), in each
case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial
owners of the Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business
Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate
entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally
in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting
from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company
or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially
the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Common Stock
and the Outstanding Company Voting Securities, as the case may be or (B) at least a majority of the members of the board of directors
(or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members
of the incumbent board at the time of the execution of the initial agreement or of the action of the board providing for such Business
Combination; or


 


(3)         A
complete liquidation or dissolution of the Company.


 






    	3



    	 



    

  


For purposes hereof, the “Excluded Persons”
shall mean William Sweedler, Tengram Capital Partners Gen2 Fund, L.P. and each of their respective Related Parties. For purposes
of hereof, “Related Party” shall mean with respect to any person or entity, any other person or entity which
(i) directly or indirectly, is controlling, controlled by or under common control with such person or entity, or (ii) directly
or indirectly, is advised, managed, administered by such person or entity or any person or entity described in the immediately
preceding clause (i). For purposes of this definition, “control” of a person or entity (including the terms “controlled
by” and “under common control with”) means the power, directly or indirectly, to direct or cause the direction
of the management or policies of such person or entity, whether through ownership of voting securities, the ability to exercise
voting power, or by contract or otherwise.


 


Except as provided in this Agreement, Executive must be in the
employ of the Company at the time of the vesting dates. The Restricted Stock was granted pursuant to a stock purchase agreement
dated as of November 19, 2012 (the “Restricted Stock Agreement”). At any time during the thirty (30) day period
following the applicable vesting date of the Restricted Stock, Executive shall have the right to “put” any vested Restricted
Stock vesting on such date to the Company at a per-share price equal to the average closing price per share of the Company’s
common stock on NASDAQ or such other registered national securities exchange on which the Company’s common stock is then-listed
over the five (5) day period preceding such purchase date (or if such stock is not then listed on any registered national securities
exchange, the fair market value of such stock as reasonably determined by the Board) for purposes of assisting the Executive in
paying all applicable taxes related to the vesting of such Restricted Stock; provided, however, that if the Company
is restricted pursuant to any contractual agreement to which it is a party or applicable law from redeeming such Restricted Stock
pursuant to the provisions hereof, the obligation to purchase any such Restricted Stock shall be suspended until the earlier to
occur of April 1st of the following calendar year and the date on which such redemption is not prohibited by any contractual
agreement to which the Company is a party or applicable law.


 


(ii) Restricted Stock Units. As of
the Effective Date, the Company shall grant to the Executive restricted stock units in respect of 300,000 shares of the Company’s
common stock, 100,000 of which shall be time-vested and 200,000 of which shall vest based on the attainment of certain share price
targets (the “RSU/PSU Award”). The RSU/PSU Award shall be made pursuant to an award agreement in the form attached
hereto as Exhibit B (the “RSU/PSU Agreement”).


 


(d)          Benefits.
Executive shall receive the employee and fringe benefits generally made available to other executive officers of the Company from
time to time, including health and dental coverage. Executive shall also be added or continued, as the case may be, as an insured
under the Company’s officers and directors insurance and all other polices which pertain to officers of the Company. The
Company shall pay Executive a car allowance of $1,500 per month during the Term.


 


(e)          Reimbursement
of Expenses. The Company shall pay to Executive the reasonable expenses incurred by him in the performance of his duties hereunder,
including, without limitation, expenses related to cell phones, blackberrys and laptop computers and such other expenses incurred
in connection with business related travel or entertainment in accordance with the Company’s policy, or, if such expenses
are paid directly by the Executive, the Company shall promptly reimburse the Executive for such payments in accordance with the
Company’s policy, provided that the Executive properly accounts for such expenses in accordance with the Company’s
policy.


 






    	4



    	 



    

  


(f)          Jewish
Holidays/Vacation. Executive shall be entitled to three weeks of paid vacation per year plus all observable Jewish holidays.
The Executive shall use his vacation in the calendar year in which it is accrued.


 


(g) Legal Fees. The Company agrees
to pay or reimburse the Executive for all reasonable attorney’s fees and related expenses incurred by the Executive in connection
with the negotiation and execution of this Employment Agreement.


 


5.           Termination
of Employment.


 


(a)          General.
The Executive’s employment under this Agreement may be terminated prior to the expiration of the Term without any breach
of this Agreement only on the following circumstances:


 


(b)          Death.
The Executive’s employment under this Agreement shall terminate upon his death.


 


(c)          Disability.
If the Executive suffers a Disability (as defined below in this sub-section (2)), the Company may terminate the Executive’s
employment under this Agreement upon thirty (30) days prior written notice; provided that the Executive has not returned to full
time performance of his duties during such thirty (30) day period. For purposes hereof, “Disability” shall mean the
Executive’s inability to perform his duties and responsibilities hereunder, with or without reasonable accommodation, due
to any physical or mental illness or incapacity, which condition either (i) has continued for a period of 180 days (including weekends
and holidays) in any consecutive 365-day period, or (ii) is projected by the Board in good faith after consulting with a doctor
selected by the Company and consented to by the Executive (or, in the event of the Executive’s incapacity, his legal representative),
such consent not to be unreasonably withheld, that the condition is likely to continue for a period of at least six (6) consecutive
months from its commencement; provided, however, that in no event shall Executive have a Disability for purposes
of this clause (c) unless Executive has become disabled within the meaning of the Company’s long term disability plan then
in effect and is entitled to receive benefits thereunder.


 


(d)          Good
Reason. The Executive may terminate his employment under this Agreement for Good Reason after the occurrence of any of the
Good Reason events set forth in the following sentence. For purposes of this Agreement, “Good Reason” shall mean the
occurrence of any of the following events without the Executive’s prior written consent:


 


(i)          the
failure by the Company to timely comply with its material obligations and agreements contained in this Agreement;


 


(ii)         a
material diminution of the authorities, duties or responsibilities of the Executive set forth in Section 1 above (other than temporarily
while the Executive is physically or mentally incapacitated and unable to properly perform such duties, as determined by the Board
in good faith) or the assignment to Executive of duties materially inconsistent with his position as Chief Executive Officer;


 






    	5



    	 



    

  


(iii) the loss of the title of
Chief Executive Officer of the Company or if, upon or following a Change in Control the Company is not the surviving entity or
survives as a subsidiary of another corporation or entity, the Executive is not the chief executive officer of the ultimate parent
corporation or entity (the “Parent”);


 


(iv) the involuntary re-location
of the Executive to an office outside of the New York, New York metropolitan area; or


 


(v) a change in the reporting
structure so that the Executive reports to someone other than the Board or, if applicable, the board of directors of the Parent;


 


provided, however, that, within ninety (90) days
of any such events having occurred, the Executive shall have provided the Company with written notice that such events have occurred
and afforded the Company thirty (30) days to cure and if the Company does not cure to Executive’s reasonable satisfaction
then Executive terminates his employment within one hundred twenty (120) days following the expiration of such cure period. For
purposes of this Agreement, upon any reduction or diminution in authorities, duties, responsibilities, etc. the basis for determining
whether such reduction or diminution was material shall be deemed to be the greatest authorities, duties, responsibilities held
by Executive and not the authorities, duties, responsibilities held by Executive immediately prior to the most recent diminution
or reduction (e.g., if the Company were to reduce Executive’s duties and then at a subsequent time were to reduce his duties
further, for purposes of determining whether the second event constitutes a Good Reason event, his duties would be compared to
those he held prior to the initial reduction).


 


(e)          Without
Good Reason. The Executive may voluntarily terminate his employment under this Agreement without Good Reason upon written notice
by the Executive to the Company at least thirty (30) days prior to the effective date of such termination (which termination the
Company may, in its sole discretion, make effective earlier than the date set forth in the Notice of Termination (as hereinafter
defined in sub-section (h) below)).


 


(f)          Cause.
The Company may terminate the Executive’s employment under this Agreement for Cause. Termination for “Cause”
shall mean termination of the Executive’s employment because of the occurrence of any of the following as determined by the
Board:


 


(i) any gross negligence or the
willful and continued failure by the Executive to substantially perform his obligations under this Agreement (other than any such
failure resulting from the Executive’s incapacity due to a Disability);


 


(ii) the indictment of the Executive
for, or his conviction of or plea of guilty or nolo contendere to, a felony;


 






    	6



    	 



    

  


(iii) the Executive’s
willfully engaging in misconduct (which shall include theft, fraud, or embezzlement) in the performance of his duties for the Company
which is injurious to the Company (monetarily or otherwise);


 


(iv) the Executive’s trading
of securities or willful disclosure of non-public information in each case constituting a violation of insider trading laws which
is injurious to the Company, monetarily or otherwise;


 


(v) any chemical dependence of
the Executive which materially and adversely affects the performance of his duties and responsibilities to the Company or any of
its subsidiaries; provided, however, that the taking of prescribed prescription medication shall not constitute a
chemical dependence of the Executive hereunder; or


 


(vi) a material breach by the
Executive of this Agreement.


 


provided, however, that in each case (other than
(ii), or (iv)), the Company shall have provided the Executive with written notice within ninety (90) days of the event(s) alleged
to constitute Cause, the Executive has been afforded at least thirty (30) days to cure same and has failed to cure the event(s)
within such 30 day period; provided, further, that in the case of willful misconduct under clause (iii), in order
to cure, the Executive shall have to cure such willful misconduct to the reasonable satisfaction of the Board.


 


(g)          Without
Cause. The Company may terminate the Executive’s employment under this Agreement without Cause immediately upon written
notice by the Company to the Executive.


 


(h)          Notice
of Termination. Any termination of the Executive’s employment by the Company or by the Executive (other than termination
by reason of the Executive’s death) shall be communicated by written Notice of Termination to the other party of this Agreement.
For purposes of this Agreement, a “Notice of Termination” shall mean a written notice which shall indicate the
specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances
claimed to provide a basis for termination of the Executive’s employment under the provision so indicated.


 


(i)          Date
of Termination. The “Date of Termination” shall mean (a) if the Executive’s employment is terminated
by his death, the date of his death, (b) if the Executive’s employment is terminated pursuant to subsection 5(c) above, thirty
(30) days after Notice of Termination is given (provided that the Executive shall not have returned to the performance of his duties
on a full-time basis during such thirty (30) day period), (c) if the Executive’s employment is terminated pursuant to subsections
5(d) or 5(f) above, the date specified in the Notice of Termination after the expiration of any applicable cure periods, (d) if
the Executive’s employment is terminated pursuant to subsection 5(e) above, the date specified in the Notice of Termination
which shall be at least thirty (30) days after Notice of Termination is given, or such earlier date as the Company shall determine,
in its sole discretion, (e) if the Executive’s employment is terminated pursuant to subsection 5(g), the date on which a
Notice of Termination is given and (f) if Executive is terminated upon expiration of the Term, the date of the expiration of the
Term.


 






    	7



    	 



    

  


(j)          Compensation
Upon Termination.


 


(i)          Termination
for Cause, without Good Reason or Expiration of Term. If the Executive’s employment shall be terminated upon the expiration
of the Term, by the Company for Cause or by the Executive without Good Reason, the Executive shall receive from the Company: (1)
any earned but unpaid Base Salary through the Date of Termination, paid in accordance with the Company’s standard payroll
practices; (2) reimbursement for any unreimbursed expenses properly incurred and paid in accordance with Section 4(e) through the
Date of Termination; (3) payment for any accrued but unused vacation time in accordance with Company policy; and (4) such benefits,
and other payments, if any, as to which the Executive (and his eligible dependents) may be entitled under, and in accordance with
the terms and conditions of, the employee benefit arrangements, plans and programs of the Company as of the Date of Termination,
other than any severance pay plan ((1) though (4), (the “Amounts and Benefits”), and the Company shall have
no further obligation with respect to this Agreement other than as provided in Section 8 of this Agreement. In addition, any portion
of the Restricted Stock Award or any other outstanding equity or incentive award that remains unvested on the Date of Termination
shall be forfeited as of the Date of Termination.


 


(ii)         Termination
without Cause or for Good Reason. If prior to the expiration of the Term, the Executive resigns from his employment hereunder
for Good Reason or the Company terminates the Executive’s employment hereunder without Cause (other than a termination by
reason of death or Disability), then the Company shall pay or provide the Executive the Amounts and Benefits and the following:


 


(1)         an
amount equal to 2.0 times the sum of (x) the then-current Base Salary and (y) the greater of (i) the actual Annual Bonus for the
year immediately preceding the year in which the Date of Termination occurs or (ii) 150% of Executive’s then-current Base
Salary. The amount payable pursuant to this Section 5(j)(ii)(1) shall be paid in full in a lump sum cash payment to be made to
the Executive on the date that is thirty (30) days following the Date of Termination;


 


(2)         any
Annual Bonus earned but unpaid for a prior year (the “Prior Year Bonus”), which shall be payable in full in
a lump sum cash payment to be made to the Executive on the date that is thirty (30) days following the Date of Termination or the
date such bonus would be paid if Executive had remained an employee of the Company, if later;


 


(3)         in
the event such resignation or termination occurs following the Company’s first fiscal quarter of any year, a pro-rata portion
of the Executive’s Annual Bonus for the fiscal year in which the Executive’s termination occurs based on actual results
for such year (determined by multiplying the amount of such Annual Bonus which would be due for the full fiscal year by a fraction,
the numerator of which is the number of days during the fiscal year of termination that the Executive is employed by the Company
and the denominator of which is 365), paid in accordance with Section 4(b) (“Pro Rata Bonus”). The Pro Rata
Bonus shall be payable at the time the Annual Bonus would have been paid if Executive’s employment had not terminated;


 






    	8



    	 



    

  


(4)         subject
to the Executive’s timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985,
as amended (“COBRA”), with respect to the Company’s group health insurance plans in which the Executive participated
immediately prior to the Date of Termination (“COBRA Continuation Coverage”), the Company shall pay the cost of COBRA
Continuation Coverage for the Executive and his eligible dependents until the earliest of (a) the Executive or his eligible dependents,
as the case may be, ceasing to be eligible under COBRA (or any COBRA-like benefits provided under applicable state law) and (b)
eighteen (18) months following the Date of Termination, (the benefits provided under this sub-section (4), the “Medical
Continuation Benefits”);


 


(5)         
any unvested portion of the Restricted Stock Award and the RSU/PSU Award shall accelerate and become fully vested on the Date of
Termination and the shares covered by the Restricted Stock Award and the RSU/PSU Award shall be distributed to the Executive on
the date that is thirty (30) days following the Date of Termination (subject to any securities law restrictions); and


 


(6) if such termination occurs
after a Change in Control (or after the execution of a definitive agreement the consummation of which would constitute a Change
in Control), any unvested PSUs shall accelerate and become fully vested on the Date of Termination and the shares covered by the
PSUs shall be distributed to the Executive on the date that is thirty (30) days following the Date of Termination (subject to any
securities law restrictions).


 


(iii)        Termination
upon Death. In the event of the Executive’s death, the Company shall pay or provide to the Executive’s estate:
(1) continued payment of the Executive’s Base Salary for the remainder of the year in which the termination for reason of
death occurs, (2) the Amounts and Benefits, (3) the Prior Year Bonus, and (4) the Pro Rata Bonus. In addition, the Restricted Stock
Award shall vest with respect to the portion of such award that was scheduled to vest in the year in which the termination for
reason of death occurs and the RSU/PSU Award shall vest in full, and such shares covered by the Restricted Stock Award and the
RSU/PSU Award shall be distributed to the Executive within thirty (30) days of the Date of Termination (subject to any securities
law restrictions).


 


(iv)        Termination
upon Disability. In the event the Company terminates the Executive’s employment hereunder for reason of Disability, the
Company shall pay or provide to the Executive: (1) the Amounts and Benefits, (2) the Prior Year Bonus, (3) a Pro Rata Bonus and
(4) the Medical Continuation Benefits. In addition, the Restricted Stock Award shall vest with respect to the portion of such award
that was scheduled to vest in the year in which the termination for reason of Disability occurs and the RSU/PSU Award shall vest
in full, and such shares covered by the Restricted Stock Award and the RSU/PSU Award shall be distributed to the Executive within
thirty (30) days of the Date of Termination (subject to any securities law restrictions). Any other unvested portion of the Restricted
Stock Award will be forfeited on the Date of Termination.


 






    	9



    	 



    

  


(v)         Payments
of Compensation Upon Termination. For the avoidance of doubt, in the event the Executive shall be entitled to receive payments
and benefits pursuant to any one of sub-sections 5(a), (b), (c) or (d) above, he shall be entitled to no payments or benefits under
any other of such sub-sections.


 


(vi)        
Release of Claims. Notwithstanding anything in this Agreement to the contrary, as a condition of receiving any payment or
benefits under Section 5(j)(ii) (other than the Amounts and Benefits), the Executive agrees to execute, deliver and not revoke
a general release and covenant not to sue in favor of the Company and its subsidiaries and their respective affiliates in substantially
the form attached here to as Exhibit A (the “Release”), before the date that is thirty (30) days following
the Date of Termination. In the event the Release is not executed and non-revocable prior to the date that is thirty (30) days
following the Date of Termination, all payments and benefits under Section 5(j)(ii) (other than the Amounts and Benefits) shall
be forfeited.


 


(vii)       No
Duty to Mitigate. The Executive shall not be required to mitigate the amount of any payment provided for in this Section 5
by seeking other employment or otherwise, nor shall the amount of any payment provided for in this Section 5 be reduced by any
compensation earned by Executive as the result of Executive’s employment by another employer or business or by profits earned
by Executive from any other source at any time before and after the Executive’s date of termination (other than as provided
in Section 5(j)(ii)(4)).


 


6.           Confidentiality.


 


(a)          The
Executive acknowledges that all customer lists and information, vendor or supplier lists and information, inventions, trade secrets,
software and computer code (whether in object code or source code format), databases, know-how or other non-public, confidential
or proprietary knowledge, information or data with respect to the products, prices, marketing, services, operations, finances,
business or affairs of the Company or its subsidiaries and affiliates or with respect to confidential, proprietary or secret processes,
methods, inventions, services, research, techniques, customers (including, without limitation, the identity of the customers of
the Company or its subsidiaries and affiliates and the specific nature of the services provided by the Company or its subsidiaries
and affiliates), employees (including, without limitation, the matters subject to this Agreement) or plans of or with respect to
the Company or its subsidiaries and affiliates or the terms of this Agreement (all of the foregoing collectively hereinafter referred
to as, “Confidential Information”) are property of the Company or its applicable subsidiaries or affiliates.
The Executive further acknowledges that the Company and its subsidiaries and affiliates intend, and make reasonable good faith
efforts, to protect the Confidential Information from public disclosure. Therefore, the Executive agrees that, except as (a) required
by law or regulation or as legally compelled by court order (provided that in such case, the Executive shall promptly notify
the Company of such order, shall cooperate with the Company in attempting to obtain a protective order or to otherwise restrict
such disclosure, and shall only disclose Confidential Information to the minimum extent necessary to comply with any such law,
regulation or order) or (b) required in order to enforce his rights under this Agreement or any other agreement with the Company
and/or its affiliates, during the Term and at all times thereafter, the Executive shall not, directly or indirectly, divulge, transmit,
publish, copy, distribute, furnish or otherwise disclose or make accessible any Confidential Information, or use any Confidential
Information for the benefit of anyone other than the Company and its subsidiaries and affiliates, unless and to the extent that
the Confidential Information becomes generally known to and available for use by the general public by lawful means and other than
as a result of the Executive’s acts or omissions or such disclosure is necessary in the course of the Executive’s proper
performance of his duties under this Agreement.


 






    	10



    	 



    

  


(b)          The
Company and its subsidiaries and affiliates do not wish to incorporate any unlicensed or unauthorized material into their products
or services. Therefore, the Executive agrees that he will not disclose to the Company, use in the Company's business, or cause
the Company to use, any information or material which is a trade secret, or confidential or proprietary information, of any third
party, including, but not limited to, any former employer, competitor or client, unless the Company has a right to receive and
use such information or material. The Executive will not incorporate into his work any material or information which is subject
to the copyrights of any third party unless the Company has a written agreement with such third party or otherwise has the right
to receive and use such material or information.


 


(c)          Notwithstanding
anything to the contrary in this Agreement, the provisions of this Section 6 shall survive any termination or non-renewal
of this Agreement.


 


7.           Noncompetition;
Non-solicitation.


 


(a)          Noncompetition.
The Executive hereby agrees that while he is employed by the Company and for the “Restricted Period” (as defined below),
he shall not, directly or indirectly, in any location in which the Company, its subsidiaries or affiliates or a licensee thereof
operates or sells its products (the “Territory”), engage, have an interest in or render any services to any
business (whether as owner, manager, operator, licensor, licensee, lender, partner, stockholder, joint venturer, employee, consultant
or otherwise) competitive with the business activities conducted by the Company, its subsidiaries or affiliates or any material
business activities of which Executive was aware that the Company or its direct or indirect subsidiaries had plans to conduct during
the time of Executive’s employment or at the time of his Date of Termination (each such case, a “Competing Business”).
Notwithstanding the foregoing, nothing herein shall prevent the Executive from owning stock in a publicly traded corporation whose
activities compete with those of the Company, its subsidiaries and affiliates, provided that such stock holdings are not
greater than five percent (5%) of such corporation. For purposes of this Agreement, the “Restricted Period” shall mean
the following: (i) in the event of a termination of employment by the Company for Cause or a resignation by the Executive without
Good Reason, a period of twelve (12) months following the Executive’s termination of employment or (ii) in the event of a
termination by the Company without Cause or a resignation by the Executive for Good Reason, a period of six (6) months following
the Executive’s termination of employment.


 






    	11



    	 



    

  


(b)          Non-solicitation.


 


(i) Employees. The Executive
shall not, while he is employed by the Company and during the period of eighteen (18) months following the Executive’s termination
of employment for any reason, directly or indirectly, (1) employ, cause to be employed or hired, recruit, solicit for employment
or otherwise contract for the services of, any individual who was or is an employee of the Company or any of its subsidiaries or
affiliates; (2) otherwise induce or attempt to induce any employee of the Company or any of its subsidiaries or affiliates to terminate
such individual’s employment with the Company or such subsidiary or affiliate, or in any way interfere with the relationship
between the Company or any such subsidiary or affiliate and any such employee.


 


(ii) Customers. The Executive
shall not, while he is employed by the Company and during the period of twelve (12) months following the Executive’s termination
of employment for any reason, solicit, contact, call upon, communicate with, or attempt to solicit, contact, call upon, communicate
with any Protected Customer (as hereinafter defined) to directly discourage such Protected Customer from doing business with the
Company or any of its subsidiaries or affiliates. For purposes of this Section 7, “Protected Customer” means
any individual or entity to whom the Company or any subsidiary or affiliate thereof has sold products or services or solicited
to sell products or services during the final twelve (12) months of Executive’s employment by the Company.


 


(c)   Company IP; Work
Product.


 


(i)          “Intellectual
Property” means all intellectual property and industrial property recognized by applicable requirements of law and all
physical or tangible embodiments thereof, including all of the following, whether domestic or foreign: (1) patents and patent applications,
patent disclosures and inventions (whether or not patentable), as well as any reissues, continuations, continuations in part, divisions,
revisions, renewals, extensions or reexaminations thereof; (2) registered and unregistered trademarks, service marks, trade names,
trade dress, logos, slogans and corporate names, and other indicia of origin, pending trademark and service mark registration applications,
and intent-to-use registrations or similar reservations of marks; (3) registered and unregistered copyrights and mask works, and
applications for registration of either; (4) Internet domain names, applications and reservations therefor, uniform resource locators
and the corresponding Internet websites (including any content and other materials accessible and/or displayed thereon); (5) Confidential
Information; and (6) intellectual property and proprietary information not otherwise listed in (1) through (6) above, including
unpatented inventions, invention disclosures, rights of publicity, rights of privacy, moral and economic rights of authors and
inventors (however denominated), methods, artistic works, works of authorship, industrial and other designs, methods, processes,
technology, patterns, techniques, data, plant variety rights and all derivatives, improvements and refinements thereof, howsoever
recorded, or unrecorded; and (7) any goodwill associated with any of the foregoing, damages and payments for past or future infringements
and misappropriations thereof, and all rights to sue for past, present and future infringements or misappropriations thereof.


 






    	12



    	 



    

  


(ii)         Work
Product. The Executive agrees to promptly disclose to the Company any and all work product, including Intellectual Property
relating to the business of the Company and any of its affiliates, that is created, developed, acquired, authored, modified, composed,
invented, discovered, performed, reduced to practice, perfected, or learned by the Executive (either solely or jointly with others)
directly relating to the Company’s and its affiliates’ business or within the scope of Executive’s employment
during the Term (collectively, “Work Product,” and together with such Intellectual Property as may be owned,
used, held for use, or acquired by the Company and its affiliates, the “Company IP”). The Company IP, including
the Work Product, is and shall be the sole and exclusive property of the Company and its affiliates, as applicable. All Work Product
that is copyrightable subject matter shall be considered a “work made for hire” to the extent permitted under applicable
copyright law (including within the meaning of Title 17 of the United States Code) and will be considered the sole property of
the Company. To the extent such Work Product is not considered a “work made for hire,” Executive hereby grants, transfers,
assigns, conveys and relinquishes, without any requirement of further consideration, all right, title, and interest to the Work
Product (whether now or hereafter existing, including all associated goodwill, damages and payments for past or future infringements
and misappropriations thereof and rights to sue for past and future infringements and misappropriates thereof) to the Company in
perpetuity or for the longest period permitted under applicable law. The Executive agrees, at the Company’s expense, to execute
any documents requested by the Company or any of its affiliates at any time to give full and proper effect to such assignment.
The Executive acknowledges and agrees that the Company is and will be the sole and absolute owner of all Intellectual Property,
including all Company IP. The Executive will cooperate with the Company and any of its affiliates, at no additional cost to such
parties (whether during or after the Term), in the confirmation, registration, protection and enforcement of the rights and property
of the Company and its affiliates in such intellectual property, materials and assets, including, without limitation, the Company
IP. The Executive hereby waives any so-called “moral rights of authors” in connection with the Work Product and acknowledges
and agrees that the Company may use, exploit, distribute, reproduce, advertise, promote, publicize, alter, modify or edit the Work
Product or combine the Work Product with other works including other Company IP, at the Company’s sole discretion, in any
format or medium hereafter devised. The Executive further waives any and all rights to seek or obtain any injunctive or equitable
relief in connection with the Work Product. Notwithstanding the above, the Executive shall have the right, subject to Section
6 hereof, to author or collaborate on one or more books or other similar works (in whatever form, including written, electronic
or otherwise) on any topic(s) whatsoever (including discussion of his experiences as an employee of the Company) (each, a “Book”),
and any such Book shall not be deemed Work Product or Company IP, and the Company shall have no claim to any rights, title or interest
in any such Book.


 






    	13



    	 



    

  


(d)          Company
Property. All Confidential Information, Company IP, files, records, correspondence, memoranda, notes or other documents (including,
without limitation, those in computer-readable form) or property relating or belonging to the Company and its subsidiaries and
affiliates, whether prepared by the Executive or otherwise coming into his possession or control in the course of the performance
of his services under this Agreement, shall be the exclusive property of the Company and shall be delivered to the Company, and
not retained by the Executive (including, without limitation, any copies thereof), promptly upon request by the Company and, in
any event, promptly upon termination of Executive’s employment hereunder. Upon termination of Executive’s employment
hereunder, the Executive shall have no rights to and shall make no further use of any Company IP, including Work Product. The Executive
acknowledges and agrees that he has no expectation of privacy with respect to the Company’s telecommunications, networking
or information processing systems (including, without limitation, stored computer files, email messages and voice messages), and
that the Executive’s activity and any files or messages on or using any of those systems may be monitored at any time without
notice. Nothing in this Section 7 shall require the Executive to return to the Company any computers or telecommunication
equipment or tangible property which he owns, including, but not limited to, personal computers, phones and tablet devices; provided,
however, that Executive shall identify each such device to the Company prior to termination of employment and either afford
the Company a reasonable opportunity to remove from all such devices any confidential or proprietary information of the Company
stored thereon or provide reasonable satisfaction to the Company that such confidential or proprietary information was removed
from such devices.


 


(e)          Enforcement.
The Executive acknowledges that a breach of his covenants and agreements contained in Sections 6 and 7 would cause irreparable
damage to the Company and its subsidiaries and affiliates, the exact amount of which would be difficult to ascertain, and that
the remedies at law for any such breach or threatened breach would be inadequate. Accordingly, the Executive agrees that if he
breaches or threatens to breach any of the covenants or agreements contained in Sections 6 and 7, in addition to any other
remedy which may be available at law or in equity, the Company and its subsidiaries and affiliates shall be entitled to institute
and prosecute proceedings in any court of competent jurisdiction for specific performance and injunctive and other equitable relief
to prevent the breach or any threatened breach thereof without bond or other security or a showing of irreparable harm or lack
of an adequate remedy at law. Additionally, upon a material breach by Executive of Section 6 or Section 7, the unvested
Restricted Stock (and any other stock-based awards held by the Executive) shall be automatically canceled and forfeited without
any further action. The Company and the Executive further acknowledge that the time, scope, geographic area and other provisions
of Sections 6 and 7 have been specifically negotiated by sophisticated commercial parties and agree that they consider the
restrictions and covenants contained in Sections 6 and 7 to be reasonable and necessary for the protection of the interests
of the Company and its subsidiaries and affiliates, but if any such restriction or covenant shall be held by any court of competent
jurisdiction to be void but would be valid if deleted in part or reduced in application, such restriction or covenant shall apply
in such jurisdiction with such deletion or modification as may be necessary to make it valid and enforceable. The Executive acknowledges
and agrees that the restrictions and covenants contained in Sections 6 and 7 shall be construed for all purposes to be separate
and independent from any other covenant, whether in this Agreement or otherwise, and shall each be capable of being reduced in
application or severed without prejudice to the other restrictions and covenants or to the remaining provisions of this Agreement.
The existence of any claim or cause of action by the Executive against the Company or any of its subsidiaries and affiliates, whether
predicated upon this Agreement or otherwise, shall not excuse the Executive’s breach of any covenant, agreement or obligation
contained in Section 6 or Section 7 and shall not constitute a defense to the enforcement by the Company or any of
its subsidiaries of such covenant, agreement or obligation; provided, however, that if upon termination of this Agreement
by the Company without “Cause” or by Executive for “Good Reason”, the Company defaults on any obligation
to pay Executive any amount due and owing Executive under Section 5(j)(ii)(1) or Section 5(j)(ii)(5), then Executive
shall not be required to comply with the undertakings set forth in Section 7(a) and Section 7(b).


 






    	14



    	 



    

  


8.           Indemnification.
The Company shall indemnify the Executive for actions taken by the Executive as an officer or director of the Company pursuant
to the fullest extent permitted by law; provided, however, that the Company shall not indemnify the Executive for
any losses incurred by the Executive as a result of or in connection with (a) acts or omissions described in Section 5(f), or (b)
a cause of action by Executive against the Company or its affiliates or their respective directors, officers, agents, representatives
or employees. If the Executive has any knowledge of any actual or threatened action, suit or proceeding, whether civil, criminal,
administrative or investigative, as to which the Executive may request indemnity under this provision, the Executive shall give
the Company prompt written notice thereof. The Company shall be entitled to assume the defense of any such proceeding, and the
Executive shall cooperate with such defense.


 


9.           Section
409A of the Code.


 


(a)          It
is intended that the provisions of this Agreement comply with Section 409A of Code and the regulations and guidance promulgated
thereunder (collectively “Code Section 409A”), and all provisions of this Agreement shall be construed in a
manner consistent with the requirements for avoiding taxes or penalties under Code Section 409A. If any provision of this Agreement
(or of any award of compensation, including equity compensation or benefits) would cause the Executive to incur any additional
tax or interest under Code Section 409A, the Company shall, upon the specific request of the Executive, use its reasonable business
efforts to in good faith reform such provision to comply with Code Section 409A; provided, that to the maximum extent practicable,
the original intent and economic benefit to the Executive and the Company of the applicable provision shall be maintained, but
the Company shall have no obligation to make any changes that could create any additional economic cost or loss of benefit to the
Company. Notwithstanding the foregoing, the Company shall have no liability with regard to any failure to comply with Code Section
409A so long as it has acted in good faith with regard to compliance therewith.


 






    	15



    	 



    

  


(b)          A
termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the
payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “Separation
from Service” within the meaning of Section 409A and, for purposes of any such provision of this Agreement, references to
a “resignation,” “termination,” “termination of employment” or like terms shall mean Separation
from Service. Any provision of this Agreement to the contrary notwithstanding, if at the time of the Executive’s Separation
from Service, the Company determines that the Executive is a “Specified Employee,” within the meaning of Code Section
409A, based on an identification date of December 31, then to the extent any payment or benefit that the Executive becomes entitled
to under this Agreement on account of such separation from service would be considered nonqualified deferred compensation under
Code Section 409A, such payment or benefit shall be paid or provided at the date which is the earlier of (i) six (6) months and
one day after such separation from service, and (ii) the date of the Executive’s death (the “Delay Period”).
Within five days of the end of the Delay Period, all payments and benefits delayed pursuant to this Section 10(b) (whether they
would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or provided to
the Executive in a lump-sum, and any remaining payments and benefits due under this Agreement shall be paid or provided in accordance
with the normal payment dates specified for them herein.


 


(c)          With
regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted by
Code Section 409A, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another
benefit, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not
affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, provided
that the foregoing clause (ii) shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b)
of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect and (iii) such
payments shall be made on or before the last day of the Executive’s taxable year following the taxable year in which the
expense was incurred.


 


(d)          Each
payment made under this Agreement shall be designated as a “separate payment” within the meaning of Code Section 409A.


 


10.         Miscellaneous.


 


(a)          This
Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed
in accordance with those laws. The Company and Executive unconditionally consent to submit to the exclusive jurisdiction of the
New York State Supreme Court, County of New York or the United States District Court for the Southern District of New York for
any actions, suits or proceedings arising out of or relating to this Agreement and the transactions contemplated hereby (and agree
not to commence any action, suit or proceeding relating thereto except in such courts), and further agree that service of any process,
summons, notice or document by registered mail to the address set forth below shall be effective service of process for any action,
suit or proceeding brought against the Company or the Executive, as the case may be, in any such court.


 






    	16



    	 



    

  


(b)          Executive
may not delegate his duties or assign his rights hereunder. No rights or obligations of the Company under this Agreement may be
assigned or transferred by the Company other than pursuant to a merger or consolidation in which the Company is not the continuing
entity, or a sale, liquidation or other disposition of all or substantially all of the assets of the Company, provided that
the assignee or transferee is the successor to all or substantially all of the assets or businesses of the Company and assumes
the liabilities, obligations and duties of the Company under this Agreement, either contractually or by operation of law. For the
purposes of this Agreement, the term “Company” shall include the Company and, subject to the foregoing, any of its
successors and assigns. This Agreement shall inure to the benefit of, and be binding upon, the parties hereto and their respective
heirs, legal representatives, successors and permitted assigns.


 


(c)          The
invalidity or unenforceability of any provision hereof shall not in any way affect the validity or enforceability of any other
provision. This Agreement reflects the entire understanding between the parties.


 


(d)          This
Agreement, the Restricted Stock Agreement and the RSU Agreement represent the entire understanding of the Executive and the Company
with respect to the employment of the Executive by the Company and contain all of the covenants and agreements between the parties
with respect to such employment. Any modification or termination of this Agreement will be effective only if it is in writing signed
by the party to be charged.


 


(e)          This
Agreement may be executed by the parties in one or more counterparts, each of which shall be deemed to be an original but all of
which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts has
been signed by each of the parties hereto and delivered to each of the other parties hereto.


 


(f)          All
amounts payable hereunder shall be subject to the withholding of all applicable taxes and deductions required by any applicable
law.


 


11.         Notices.
All notices relating to this Agreement shall be in writing and shall be either personally delivered, sent by telecopy (receipt
confirmed) or mailed by certified mail, return receipt requested, to be delivered at such address as is indicated below, or at
such other address or to the attention of such other person as the recipient has specified by prior written notice to the sending
party. Notice shall be effective when so personally delivered, one business day after being sent by telecopy or five days after
being mailed.


 


To the Company:


 


Sequential Brands Group, Inc.


c/o Tengram Capital Management, LLC


15 Riverside Avenue


Westport, CT 06880


Attention: Bill Sweedler


 






    	17



    	 



    

  


With a copy to:


 


Sequential Brands Group, Inc.


5 Bryant Park


30th Floor


New York, NY 10018


Attention: Bill Sweedler


 


To the Executive:


 


Mr. Yehuda Shmidman


376 West 245th Street


Bronx, NY 10471


 


 


 


 


 


 


With a copy to:


 


Donald P. Carleen


Fried, Frank,
Harris, Shriver & Jacobson LLP


One New York Plaza


New York, NY 10004


Fax: (212) 859-4000


 


[signature page follows]


 






    	18



    	 



    

   


IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the 14th day of April, 2015.


 


 





	 	 	SEQUENTIAL BRANDS GROUP, INC.
	 	 	 	 
	 	 	By:	/s/ William Sweedler




	 	 	Name:	 William Sweedler
	 	 	Title:	Chairman of the Board of Directors




	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	EXECUTIVE	 	 	 
	 	 	 	 
	 	 	 	 
	/s/ Yehuda Shmidman	 	 	 
	Yehuda Shmidman	 	 	 



 






    	19



    	 



    

 






EXHIBIT A


 


EXECUTIVE RELEASE AND COVENANT NOT
TO SUE


 


Except as otherwise
provided herein, in consideration of the severance payments and/or benefits I am eligible to receive pursuant to the employment
agreement between Sequential Brands Group, Inc., a Delaware corporation (the “Company”), and me, dated ____________,
2015 (the “Employment Agreement”), I, Yehuda Shmidman, on behalf of myself, and on behalf of my heirs, successors
and assigns, hereby knowingly and voluntarily release and discharge, to the fullest extent permitted by law, the Company. and all
of their respective past and present subsidiaries, affiliates, predecessors, successors and assigns (“Company Entities”)
and, with respect to each and all of the Company Entities, all of their respective directors, officers, employees, agents, each
individually and in their representative capacities (“Company Entity Officials”) (Company Entities and Company Entity
Officials collectively referred to herein as “Released Parties”) from any and all claims, demands, agreements,
obligations, expenses, actions, judgments and liabilities of any kind whatsoever, in law, equity or otherwise, whether known or
unknown, suspected or claimed, specifically mentioned herein or not, which I had, have or may have against any of the Released
Parties by reason of any actual or alleged act, event, occurrence, omission, practice or other matter whatsoever from the beginning
of time up to and including the date that I sign this Separation and General Release Agreement (this “Claims”), including
that but not limited to Claims arising out of or in any way relating to: (i)  my employment with any and all of the Company
Entities, including the termination of that employment; (ii) any common law, public policy, company policy, contract (whether oral
or written, express or implied) or tort law having any bearing whatsoever on the terms and conditions of my employment; and/or
(iii) any federal, state or local law, ordinance or regulation including, but not limited to, the following (each as amended, if
applicable): Age Discrimination in Employment Act (including Older Workers Benefit Protection Act); Americans with Disabilities
Act; Civil Rights Act of 1866; Civil Rights Act of 1991; Equal Pay Act; Family and Medical Leave Act of 1993; National Labor Relations
Act; Title VII of the Civil Rights Act of 1964; Worker Adjustment and Retraining Notification Act; New York State and New York
City Human Rights Laws; New York State Labor Law; New York State Worker Adjustment and Retraining Notification Act; and any other
law, ordinance or regulation regarding discrimination or harassment or terms or conditions of employment.


 


I agree that I have
entered into this Release as a compromise and in full and final settlement of all Claims, if any, that I have or may have against
any and all of the Released Parties up to and including the date that I sign this Release (except as otherwise expressly set forth
below). I also agree that, although I may hereafter discover Claims presently unknown or unsuspected, or new or additional facts
from those which I now knows or believe to be true, I intend to provide a complete waiver of all Claims based on any facts
and circumstances, whether known or unknown, up to and including the date that I sign this Agreement (except as otherwise expressly
set forth below).


 


However, notwithstanding
the foregoing, I am not releasing, and for the avoidance of doubt Claims do not include, my rights, if any, (i) to indemnification
by the Company or any of its affiliates, to the maximum extent permitted by law, for all claims or proceedings, or threatened claims
or proceedings, arising out of or relating to my service as an officer, director or employee, as the case may be, of the Company
or any of its subsidiaries, (ii) to payment of any authorized but unreimbursed business expenses incurred prior to the termination
of my employment with the Company or any of its subsidiaries in accordance with Section 4(e) of my Employment Agreement, (iii)
under any employee pension or welfare plan or program in which I participate or participated, (iv) to receive payments, severance
and benefits under Section 5(j) of the Employment Agreement, (v) to be indemnified pursuant to Section 8 of the Employment Agreement
or pursuant to other agreements to which I may be entitled to indemnification, and (vi) to any equity awards I have received prior
to the date of termination of my employment, including the Restricted Stock Award, the RSU/PSU Award and the PSUs. Furthermore,
I am not releasing any rights or claims that may arise after the date on which I sign this Release or that cannot be released by
a private settlement agreement (such as statutory claims for worker’s compensation/disability insurance benefits and unemployment
compensation).


 






    	20



    	 



    

  


I represent that I
have not assigned or transferred my rights with respect to any Claims covered by this Release and that I have not filed, directly
or indirectly any legal proceeding against the Released Parties regarding any such Claims. If I commence (or commenced) or participate
in any action or proceeding (including as a member of a class of persons) regarding Claims covered by this Release, I acknowledge
and agree that this Release shall be a complete defense in such action or proceeding and, to the maximum extent permitted by law,
I and my heirs, successors and assigns will have no right to obtain or receive, and will not seek or accept, any damages, settlement
or relief of any kind (including attorneys’ fees and costs) as a result of such action or proceeding.


 


In addition, I acknowledge
and agree that I am and will continue to be bound by the terms and conditions set forth in the Employment Agreement (including
the restrictive covenants) (the “Continuing Obligations”),all of which continue to remain in full force and
effect for the periods set forth therein notwithstanding the termination of my employment and are hereby incorporated herein by
reference.


 


In further consideration
of the payment and/or benefits I am eligible to receive pursuant to the Employment Agreement, I agree to reasonably cooperate with
the Company Entities, their legal counsel and designees regarding any current or future claim, investigation (internal or otherwise),
inquiry or litigation relating to any matter with which I was involved or had knowledge or which occurred during my employment,
with such assistance including, but not limited to, meetings and other consultations, signing affidavits and documents that are
factually accurate, attending depositions and providing truthful testimony (in each case, without requiring a subpoena); provided,
however, that the Company will reimburse me for my reasonable expenses (including attorneys’ fees and travel expenses)
actually incurred by me in connection with such cooperation (it being understood that if any such expenses are expected to exceed
$5,000, Executive shall inform the Company prior to incurring such expenses to provide the Company with an opportunity to either
agree to reimburse Executive for such expenses or advise Executive not to provide such cooperation necessitating the incurrence
of such expenses).


 






    	21



    	 



    

  


I acknowledge and agree that:


 


1.The payment and/or
benefits I am receiving under the Employment Agreement constitute consideration over and above any payments and/or benefits that
I might be entitled to receive without executing this Release.


 


2.The Company advised
me to consult with an attorney prior to executing this Release.


 


3.I was given a
period of at least 21 days within which to consider this Release and that I must sign and return this Release no later than __________,
201_.


 


4.The Company has
advised me of my statutory right to revoke my acceptance of the terms of this Release at any time within seven (7) days of my signing
of this Release.


 


5.I warrant and
represent that my decision to accept this Release was (a) entirely voluntary on my part; (b) not made in reliance on any inducement,
promise or representation, whether express or implied, other than the inducements, representations and promises expressly set forth
in the Employment Agreement or in the Release; and (c) did not result from any threats or other coercive activities to induce
acceptance of this Release.


 


In the event I decide
to exercise my right to revoke within seven (7) days of my acceptance of this Release, I warrant and represent that I will do the
following: (1) notify the Company in writing of my intent to revoke my agreement, and (2) simultaneously return in full the consideration,
if any, received from the Company Entities pursuant to the Employment Agreement and which consideration was expressly subject to
my signing this Release.


 


Upon its effectiveness,
this Release, the Employment Agreement and the Continuing Obligations, together with any applicable equity award agreements and
equity plans, contains the entire agreement and understanding of the parties relating to the subject matter hereof and supersedes
and replaces all prior and contemporaneous agreements, representations and understandings (whether oral or written) regarding the
subject matter hereof. Once executed by me, this Release may be modified only in a document signed by me and the Company and referring
specifically hereto, and no handwritten changes to this Release will be binding unless initialed by me and the Company. If any
portion of this Release is held to be unenforceable by any court of competent jurisdiction, the parties intend that such portion
be modified to make it enforceable to the maximum extent permitted by law. If any such portion (other than the general release
provisions) cannot be modified to be enforceable, such portion shall become null and void leaving the remainder of this Release
in full force and effect.


 


This Release shall
be binding upon and inure to the benefit of (i) the Released Parties, including the successors and assigns of the Released
Parties, all of which are intended third-party beneficiaries, and (ii) me and my heirs, successors and assigns. This Release is
not an admission of liability or wrongdoing by me or any of the Released Parties, and such wrongdoing or liability is expressly
denied.


 






    	22



    	 



    

  


I further warrant and
represent that I fully understand and appreciate the consequence of my signing this Release and that I am signing it voluntarily.


 


IN WITNESS WHEREOF,
I hereby acknowledge receipt of consideration and execute the foregoing agreement at              ,
this day of             , 20  .


 


	 	 
	 	Yehuda Shmidman


 


Witnessed by        
on this          day of          ,
20   .


 


	 	 
	 	WITNESS


 






    	23